• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从外来病毒易感性的角度来看,NIID-MDCK 细胞作为细胞基流感疫苗开发的基质的适用性。

Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.

机构信息

Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.

Yamagata Prefectural Institute of Public Health, Yamagata, Japan.

出版信息

Microbiol Immunol. 2022 Jul;66(7):361-370. doi: 10.1111/1348-0421.12985. Epub 2022 Jun 8.

DOI:10.1111/1348-0421.12985
PMID:35545856
Abstract

The practical use of cell-based seasonal influenza vaccines is currently being considered in Japan. From the perspective of adventitious virus contamination, we assessed the suitability of NIID-MDCK cells (NIID-MDCK-Cs) as a safe substrate for the isolation of influenza viruses from clinical specimens. We first established a sensitive multiplex real-time PCR system to screen for 27 respiratory viruses and used it on 34 virus samples that were isolated by passaging influenza-positive clinical specimens in NIID-MDCK-Cs. Incidentally, the limit of detection (LOD) of the system was 100 or fewer genome copies per reaction. In addition to influenza viruses, human enterovirus 68 (HEV-D68) genomes were detected in two samples after two or three passages in NIID-MDCK-Cs. To further investigate the susceptibility of NIID-MDCK-Cs to adventitious viruses, eight common respiratory viruses were subjected to passages in NIID-MDCK-Cs. The genome copy numbers of seven viruses other than parainfluenza 3 decreased below the LOD by passage 4. By passaging in NIID-MDCK-Cs, the genome numbers of the input HEV-D68, 1 × 10 copies, declined to 10 at passage 3 and to under the LOD at passage 4, whereas those of the other six viruses were under the LOD by passage 3. These results implied that during the process of isolating influenza viruses with NIID-MDCK-Cs, contaminating viruses other than parainfluenza 3 can be efficiently removed by passages in NIID-MDCK-Cs. NIID-MDCK-Cs could be a safe substrate for isolating influenza viruses that can be used to develop cell-based influenza vaccine candidate viruses.

摘要

细胞季节性流感疫苗在日本的实际应用目前正在考虑中。从外来病毒污染的角度出发,我们评估了 NIID-MDCK 细胞(NIID-MDCK-Cs)作为从临床标本中分离流感病毒的安全基质的适用性。我们首先建立了一种敏感的多重实时 PCR 系统来筛选 27 种呼吸道病毒,并将其应用于通过在 NIID-MDCK-Cs 中传代流感阳性临床标本分离的 34 个病毒样本。该系统的检测限(LOD)为每个反应 100 个或更少的基因组拷贝。除流感病毒外,在 NIID-MDCK-Cs 中传代两次或三次后,从两个样本中检测到人类肠道病毒 68 型(HEV-D68)基因组。为了进一步研究 NIID-MDCK-Cs 对外来病毒的易感性,将八种常见的呼吸道病毒在 NIID-MDCK-Cs 中进行传代。除副流感 3 型以外的七种病毒的基因组拷贝数在传代 4 次后降至 LOD 以下。通过在 NIID-MDCK-Cs 中传代,输入的 HEV-D68 的基因组数从 1×10 拷贝下降到 3 次传代时的 10 拷贝,到 4 次传代时降至 LOD 以下,而其他六种病毒的基因组数在 3 次传代时已低于 LOD。这些结果表明,在用 NIID-MDCK-Cs 分离流感病毒的过程中,除副流感 3 型以外的污染病毒可以通过在 NIID-MDCK-Cs 中传代来有效去除。NIID-MDCK-Cs 可作为一种安全的基质来分离可用于开发细胞基流感疫苗候选病毒的流感病毒。

相似文献

1
Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.从外来病毒易感性的角度来看,NIID-MDCK 细胞作为细胞基流感疫苗开发的基质的适用性。
Microbiol Immunol. 2022 Jul;66(7):361-370. doi: 10.1111/1348-0421.12985. Epub 2022 Jun 8.
2
Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity.评估一种合格的 MDCK 细胞系用于病毒分离,以开发具有适当抗原性的细胞基流感疫苗病毒。
Vaccine. 2024 Oct 3;42(23):126242. doi: 10.1016/j.vaccine.2024.126242. Epub 2024 Aug 29.
3
Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.悬浮 MDCK 细胞、贴壁 MDCK 细胞和 LLC-MK2 细胞用于选择性分离流感病毒作为疫苗种子的比较。
Influenza Other Respir Viruses. 2020 Mar;14(2):204-209. doi: 10.1111/irv.12694. Epub 2019 Oct 25.
4
Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.用于生产基于MDCK细胞培养的流感疫苗的细胞传代病毒和鸡胚传代病毒的免疫原性比较。
Virus Res. 2015 Jun 2;204:40-6. doi: 10.1016/j.virusres.2015.04.005. Epub 2015 Apr 17.
5
Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.开发一种甲型流感主病毒,用于在合格的犬肾传代细胞(MDCK细胞)中产生高生长重配体,以生产A/安徽/1/2013(H7N9)疫苗。
PLoS One. 2016 Jul 25;11(7):e0160040. doi: 10.1371/journal.pone.0160040. eCollection 2016.
6
Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses.在 MDCK 33016PF 细胞中分离流感病毒并清除污染的呼吸道病毒。
Vaccine. 2012 Jan 11;30(3):517-22. doi: 10.1016/j.vaccine.2011.11.063. Epub 2011 Nov 24.
7
High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.稳定敲低 IRF7 可提高犬肾细胞(MDCK)中流感病毒的高产率。
PLoS One. 2013;8(3):e59892. doi: 10.1371/journal.pone.0059892. Epub 2013 Mar 26.
8
Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.悬浮 MDCK 细胞、贴壁 MDCK 细胞和 LLC-MK2 细胞用于制备流感疫苗种子病毒的系统评价。
Vaccine. 2019 Oct 8;37(43):6526-6534. doi: 10.1016/j.vaccine.2019.08.064. Epub 2019 Sep 6.
9
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.用于流感病毒分离和增殖以生产疫苗的合格细胞系的性能特征。
Vaccine. 2014 Nov 12;32(48):6583-90. doi: 10.1016/j.vaccine.2014.06.045. Epub 2014 Jun 24.
10
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.作为一种减轻流感疫苗病毒种子中偶然污染物风险的方法,斑块纯化。
Vaccine. 2011 Apr 12;29(17):3155-61. doi: 10.1016/j.vaccine.2011.02.041. Epub 2011 Feb 26.

引用本文的文献

1
Micro RNA-175 Targets to Inhibit Madin-Darby Canine Kidney Cell Adhesion.MicroRNA-175 靶向抑制 Madin-Darby 犬肾细胞黏附。
Genes (Basel). 2024 Oct 16;15(10):1333. doi: 10.3390/genes15101333.
2
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations.基于细胞培养的流感疫苗制造创新——从静态培养到高密度培养。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2373521. doi: 10.1080/21645515.2024.2373521. Epub 2024 Jul 15.
3
Developments and current challenges in the process of cell culture-based seasonal influenza vaccine manufacture in Japan.
日本基于细胞培养的季节性流感疫苗生产过程中的发展与当前挑战。
Glob Health Med. 2024 Apr 30;6(2):93-100. doi: 10.35772/ghm.2023.01070.